µ¼Ê¦ÐÕÃû£ºÕŲ¨
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º299
ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£ºµÚ¶þÁÙ´²Ñ§Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º²©µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÉñ¾Íâ¿Æ
Ñо¿ÁìÓò£º Éñ¾Ö×Áö¼°ÄÔѪ¹Ü²¡µÄÁÙ´²ºÍ»ù´¡Ñо¿
Ñо¿ÁìÓò£º Éñ¾Ö×Áö¼°ÄÔѪ¹Ü²¡µÄÁÙ´²ºÍ»ù´¡Ñо¿ [ÊÕÆð]
ͨѶ·½Ê½ :
µç×ÓÓʼþ£ºzhangbodl@126.com
¸öÈ˼òÊö :
ÏÖΪ´óÁ¬Ò½¿Æ´óѧ¸½ÊôµÚ¶þÒ½ÔºÉñ¾Íâ¿ÆÑ§¿Æ´øÍ·ÈË£¬½ÌÊÚ£¬Ö÷ÈΣ¬²©Ê¿Éúµ¼Ê¦¡£ÁÉÄþÊ¡ÌØÆ¸½ÌÊÚ£¬ÁÉÄþÊ¡¡°°ÙǧÍòÈ˲ʤ³Ì¡±°ÙÈ˲ã´ÎÈËÑ¡£¬ÁÉÄþÊ¡ÁÙ´²Öصãר¿Æ£¨Éñ¾Íâ¿Æ£©¸ºÔðÈË£¬ÁÉÄþÊ¡Éñ¾ÏµÍ³ÖØ´ó¼²²¡´´ÐÂÍŶӵÄÖ÷Òª¸ºÔðÈË£¬ÃÀ¹ú»ôÆÕ½ð˹¡¢¹þ·ðÂéÊ¡×ÜÒ½ÔºµÈÒ½Ôº·ÃÎÊѧÕß¡£µ£ÈÎÖйúҽʦѧ»áÀÏÄêҽѧ·Ö»áίԱ£¬Öйú´¹ÌåÏÙÁöÐ×÷×éר¼ÒίԱ»áίԱ£¬ÖйúÆ÷¹ÙÒÆÖ²·¢Õ¹»ù½ð»áר¼ÒίԱ»áίԱ£¬ÁÉÄþʡϸ°ûÉúÎïѧѧ»áÉñ¾Ö×Áö·Ö»áÖ÷ÈÎίԱ¡¢ÁÉÄþÊ¡Éñ¾¿ÆÑ§Ñ§»áÀíÊ¡£Ö÷³Ö¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð¡¢¹ú¼Ò863¼Æ»®¡¢¹ú¼Ò¿Æ¼¼Ö§³Å¼Æ»®µÈ¿ÎÌâ20ÓàÏ·¢±íѧÊõÂÛÎÄ60ÓàÆª£¬ÆäÖб»SCIÊÕ¼30ÓàÆª£¬Ïà¹Ø³É¹û»ñÊ¡²¿¼¶¿Æ¼¼½ø²½Ò»µÈ½±1Ïî¡¢¶þµÈ½±3Ïî¡¢ÈýµÈ½±2ÏÊм¶¿Æ¼¼½ø²½¶þµÈ½±2Ïî¡£¹ú¼ÊÉñ¾Íâ¿ÆÈ¨ÍþÖø×÷¡¶ÓÈÂü˹Éñ¾Íâ¿ÆÑ§¡·¸±Ö÷Ò룬²Î±à¡¶Âµ×Íâ¿ÆÑ§¡·¡¢¡¶Éñ¾Íâ¿ÆÊÖÊõѧ¡·µÈÒ½Ñ§Öø×÷6²¿¡£
¿ÆÑй¤×÷ :
ÔÚÑÐÏîÄ¿1.¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð£º»·×´RNA CDR1asͨ¹ýÓëp53ÐγÉÕý·´À¡»ØÂ·µ÷¿Ø½ºÖÊÁö¶ñÐÔÉú³¤µÄ·Ö×Ó»úÖÆ£¨**£©£¬2017.01-2020.12,57Íò£¬¿ÎÌ⸺ÔðÈË
2.¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð£ºDNA¼×»ù»¯Ñõ»¯Í¨Â·È±Ê§´Ù½ø´¹ÌåÁöÇÖÏ®ÐÔÉú³¤µÄ·Ö×Ó»úÖÆºÍÁÙ´²ÒâÒ壨**£©£¬2014.01-2017.12£¬70Íò£¬¿ÎÌ⸺ÔðÈË
3.ÁÉÄþÊ¡×ÔÈ»¿ÆÑ§»ù½ð£º»·×´RNA CDR1as ͨ¹ýÔöÇ¿p53ºËËáÎȶ¨ÐÔÒÖÖÆ´¹ÌåÏÙÁöÇÖÏ®ÐÔÉú³¤µÄ·Ö×Ó»úÖÆ¼°ÁÙ´²ÒâÒ壨**£©£¬2016-2018£¬5Íò£¬¿ÎÌ⸺ÔðÈË
4.ÁÉÄþÊ¡°ÙǧÍòÈ˲Å×ÊÖúÏîÄ¿£¨**£©£º»·×´RNA GRNasÔÚ½ºÖÊÁö·¢Éú·¢Õ¹ÖеÄ×÷ÓûúÖÆ¼°ÁÙ´²ÒâÒ壬2015.01-2016.12£¬2Íò£¬¿ÎÌ⸺ÔðÈË
´ú±íÎÄÕÂ
1.Gamabufotalin triggers c-Myc degradation via induction of WWP2 in multiple myeloma cells*. Oncotarget. 2016,7(13):15725-37 doi: 10.18632/oncotarget.7398. (IF:5.007)£¬Í¨Ñ¶×÷Õß¡£2.CDKN2A/B rs** and glioma risk: a meta-analysis*.Int J Clin Exp Med, 2016,9(2): 2590-2594(IF: 1.075) £¬Í¨Ñ¶×÷Õß¡£3.miR-133 inhibits pituitary tumor cell migration and invasion via down-regulating FOXC1 expression*. Genet Mol Res. 2016 Mar 2415(1). (IF:0.764) £¬Í¨Ñ¶×÷Õß¡£4.Effect of Alkaloids Isolated from Phyllodium pulchellum on Monoamine Levels and Monoamine Oxidase Activity in Rat Brain*. Evidence-Based Complementary and Alternative Medicine.2016. (IF: 1.931) £¬Í¨Ñ¶×÷Õß¡£5.Protostane alisol derivatives from the rhizome of Alisma orientale*. Phytochemistry Letters,2016,168-11. (IF: 1.353) £¬Í¨Ñ¶×÷Õß¡£6.Oculomotor Paralysis, Postorbital Pain, and Hypopituitarism as First Presentations of Metastatic Gastric Cancer in the Pituitary Flourished by Internal Carotid Aneurysm: A Case Report*. Medicine (Baltimore). 2015,94(50): e2317. (IF:1.206) £¬Í¨Ñ¶×÷Õß¡£7.Nerve regeneration and functional recovery by collagen-binding brain-derived neurotrophic factor in an intracerebral hemorrhage model#. Tissue Eng Part A. 2015 ,21(1-2):62-74.(IF: 3.892)£¬µÚÒ»×÷Õß¡£8.Statins for the prevention of stroke: a meta-analysis of randomized controlled trials*. PLoS One. 2014 ,9(3): e92388. (IF: 3.234) £¬Í¨Ñ¶×÷Õß¡£9.Pyrimethamine sensitizes pituitary adenomas cells to temozolomide through cathepsin B-dependent and caspase-dependent apoptotic pathways#. Int J Cancer. 2013 ,133(8):1982-1993. (IF: 5.007) £¬µÚÒ»×÷Õß¡£10.Inhibition of PI3K/AKT/mTOR pathway enhances temozolomide-induced cytotoxicity in pituitary adenoma cell lines in vitro and xenografted pituitary adenoma in female nude mice#. Endocrinology. 2013 ,154(3):1247-1259. (IF: 4.644) £¬µÚÒ»×÷Õß¡£
´óÁ¬Ò½¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÕŲ¨
±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø/2019-05-27
Ïà¹Ø»°Ìâ/Éñ¾ ÁÙ´² Ö×Áö »ù´¡ Íâ¿ÆÑ§
ÏëҪдºÃÓ¢Óï×÷ÎÄ 2020öλÔÓéÀÖ¹Ù·½appÏÂÔØÓ¢Óï»ù´¡½×¶Î±Ø±¸¾äÐÍ
¡¡¡¡1) Èç¹ûËûÒª¸ÉµÄ»°£¬ÄÇÒ²ºÃ¡£If he will do it, well and good.¡¡¡¡2) Èç¹û´«ÎÅÊÇÕæµÄ£¬ÄǸÃÔõô°ì?What if the rumor is true?¡¡¡¡3) ÎÒ»á¸æËßÄãÊÂÇéµÄÕæÏàµÄ¡£I will tell you whats what.¡¡¡¡4) ³ý·ÇÌ«Ñô´ÓÎ÷±ß³öÀ´£¬Ëû²Å»áͬÒâ¡£He will agree when three Sundays come in a week.¡¡¡¡5) ÄãµÄ»Ø´ð²»ÇÐÌâ¡£Yo ...Ó¢Óï×÷ÎÄ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-26Î人´óѧ313Àúʷѧ»ù´¡¸ÐÎòÓëÐĵ÷ÖÏí
2019öλÔÓéÀÖ¹Ù·½appÏÂÔØ£¬Ä¿Ç°»ù±¾ÉÏÒѾ½áÊøÁË£¬ÎÒ¿¼ÁËÁ½´Î£¬½ñÄê¼ȡÁËÎ人´óѧרÃÅÊ··½Ïò¡£Ä¿Ç°Ë仹δÊÕµ½Í¨ÖªÊ飬µ«ÓÐѧµÜѧÃÃÔøÀ´ÏòÎÒÇë½ÌһЩ¸´Ï°ÉϵÄÎÊÌ⣬ÎÒÒ²Ïë³Ã´Ë»ú»á»Ø¹ËÒ»ÏÂ×Ô¼ºÁ½ÄêµÄöλÔÓéÀÖ¹Ù·½appÏÂÔØÀú³Ì¡£ÎÒÔøÔÚÎä´óµÄÎÄÊ·°å¿é¿ªÁËÒ»¸öÌû×Ó£¬Ëµ»¶Ó¸÷λѧµÜѧÃÃ×ÉѯöλÔÓéÀÖ¹Ù·½appÏÂÔØµÄ¾ßÌåÇé¿ö£¬µ«´ó¼ÒËÆºõ¶¼±È½Ï棬Ìû×ӾͳÁÁË¡£½ñÌìÕâÆª£¬ÊÇÕý¶ù ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØ¾Ñé Š^Á¦“Üë…ég Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-15ÖйúÈËÃñ´óѧ°æ¡¶»á¼ÆÑ§»ù´¡¡·¿Îºó´ð°¸
½Ì²ÄÁ·Ï°²Î¿¼´ð°¸ P67Á·Ï°ÌâÒ»£¨¼û±í£© öλÔÓéÀÖ¹Ù·½appÏÂÔØÐòºÅÓ¦¹éÊô»á¼ÆÒªËØÀà±ð¼°½ð¶îÓ¦¹éÊô»á ¼Æ¿ÆÄ¿×ʲú¸ºÕ®ËùÓÐÕßÈ¨ÒæÀý£º£¨1£©1 000ÏÖ ½ð£¨2£© 300 000ÒøÐдæ¿î£¨3£© 19 000Ô²ÄÁÏ £¨4£© 900 000¹Ì¶¨×ʲú£¨5£© 800 000¹Ì¶¨Ì¿²ú £¨6£© 1 755 000ʵÊÕ×ʱ¾£¨7£© 80000Ó¦ÊÕÕË ¿î£¨8£© 120 000¶ÌÆÚ½è¿î£¨9£© 50 000¿â ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-14ÕÔÆé½ÌÊڿμþöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±±º½Í¨ÐÅöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£¨921£©öλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØÖ®µç×ӵ緻ù´¡
.. ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-14ÕÅÏþÁÖ½ÌÊڿμþöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±±º½Í¨ÐÅöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£¨921£©öλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØÖ®µç×ӵ緻ù´¡
.. ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-14ÕÅ·ïÑÔ°æµç×ӵ緻ù´¡¿Î¼þ
µÚÒ»Õ ¼¯³Éµç·Ԫ¡¢Æ÷¼þ»ù´¡£¨1.1~1.3£© µÚ¶þÕ ģÄ⼯³É»ù±¾µ¥Ôªµç·»ù´¡£¨2.1~2.5£© µÚÈýÕ ·Å´óµç·µÄƵÂÊÌØÐÔ£¨3.1~3.3£© µÚËÄÕ ¼¯³ÉÔ˷ż°ÆäÓ¦Óã¨4.1~4.2¼ò½é£¬Öص㽲4.4ºÍ4.6£© µÚÆßÕ µçÁ÷Ä£µç·»ù´¡£¨2.6£¬4.5.3~4.5.4£¬8.2£© µÚÎåÕ ·Å´óµç··´À¡ÔÀíÓëÎȶ¨»¯»ù´¡£¨5.1~5.6£© µÚÁùÕ MOSÄ£Äâ ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-14Êý×ֵ緻ù´¡µÚÎå°æµÄ¿ÎºóϰÌâ½â´ð
.. ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-12ÉϺ£½»Í¨´óѧ¿ØÖÆÀíÂÛ»ù´¡PPT¿Î¼þ
ÉϺ£½»´ó¿ØÖÆÀíÂÛ»ù´¡¿Î¼þ__µÚ02ÕÂ_ÊýѧģÐÍ.ppt 4.9 MB 2010-09-03 00:22 -a-- ÉϺ£½»´ó¿ØÖÆÀíÂÛ»ù´¡¿Î¼þ__µÚ03ÕÂ_ƵÂÊÌØÐÔ.ppt 3.6 MB 2010-09-03 00:21 -a-- ÉϺ£½»´ó¿ØÖÆÀíÂÛ»ù´¡¿Î¼þ__µÚ04ÕÂ_Îȶ¨ÐÔ.ppt 2.6 MB 2010-09-03 00:19 -a-- ÉϺ£½»´ó¿ØÖÆÀíÂÛ»ù´¡¿Î¼þ__µÚ05ÕÂ_Îó²î·ÖÎö.ppt ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-12ÉϺ£½»Í¨´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØ815¿ØÖÆÀíÂÛ»ù´¡1996-2005öλÔÓéÀÖ¹Ù·½appÏÂÔØÕæÌâÏêϸ´ð°¸
.. ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-12ÏÃÃÅ´óѧ΢²¨¼¼Êõ»ù´¡µç×ӽ̰¸
20¡«50Äê´ú£¬ËùÓеÄ΢²¨É豸¾ù²ÉÓýðÊô²¨µ¼£«Í¬ÖáÏß¡£ º½¿Õ¡¢º½Ìì¼¼Êõ·¢Õ¹&С¡¢Çá¡¢¿É¿¿¡£ &50Äê´ú£¬µÚÒ»´ú΢²¨Ó¡ÖÆ´«ÊäÏß&´ø×´Ïß &60Äê´ú£¬µÚ¶þ´ú΢²¨Ó¡ÖÆ´«ÊäÏß &΢´øÏߣº÷¢Ïß¡¢²ÛÏß¡¢¹²Ã沨µ¼¡¢¹²Ãæ´ø×´Ïߣ¨Î¢²¨¼¯³É´«ÊäÏߣ© ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-11ÄϾ©Ê¦·¶´óѧӢÓïÓïÑÔÎÄѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØ¸´Ï°Ö¸ÄÏ»ù´¡°à¸¨µ¼ÄÚ²¿½²Òå
.. ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-10¿ØÖÆÀíÂÛ»ù´¡Ï°ÌâÓë½â´ð
¡¶¿ØÖÆÀíÂÛ»ù´¡¡·×Ô1980Äê³ö°æÒÔÀ´,±»È«¹ú¶à¸CµÈѧУѡ×÷½Ì²Ä¡£1990Äê¸ÃÊé¾ ¹ýÖØÐÂÐÞ¶©ºóÓɹú·À¹¤Òµ³ö°æÉçÔٴγö°æ¡£ÕâÆÚ¼ä£¬ÏȺó²»ÉÙ½Ìʦ¡¢Ñ§ÉúºÍ¹¤³Ì¼¼Êõ&ÈËÔ± Ìá³ö×îºÃÄÜÔÙ±àдһ±¾Ï°ÌâÓë½â´ð£¬ÒÔ°ïÖú¼ÓÉî¶Ô½Ì²ÄÄÚÈݵÄÀí½âºÍÓÐÖúÓÚ×Ôѧ¡£Õâ±¾ ¡¶Ï°ÌâÓë½â´ð¡·¾ÍÊÇÔÚÕâÖÖÇé¿öÏ£¬¸ù¾Ý¶àÄê½ÌѧµÄ»ýÀÛ£¬ÔÚÔÀ´±àдµÄ¡¶¿ØÖÆ ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-10»ªÄÏÀí¹¤´óѧÍÁÁ¦Ñ§ÓëµØ»ù»ù´¡PPT¿Î¼þ
Ö÷½²: ÁõÔöÈÙ ½ÌÊÚ ½Ì²Ä: µØ»ù¼°»ù´¡ Ö÷±à: »ªÄÏÀí¹¤´óѧµÈԺУ ³ö°æÉç:Öйú½¨Öþ¹¤Òµ³ö°æÉç Ð÷ ÑÔ Ò»¡¢ ÍÁÁ¦Ñ§¡¢µØ»ù¼°»ù´¡µÄÓйظÅÄî 1 ÍÁÁ¦Ñ§--Ñо¿ÍÁµÄÓ¦Á¦¡¢±äÐΡ¢Ç¿¶ÈºÍÎȶ¨ÒÔ¼°ÍÁÓë½á¹¹ÎïÏ໥×÷ÓõȹæÂɵÄÒ»ÃÅÁ¦Ñ§·ÖÖ§³ÆÎªÍÁÁ¦Ñ§¡£ 2 µØ ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-09¶«ÄÏ´óѧµç·»ù´¡PPT¿Î¼þ
¶«ÄÏ´óѧÊý×ֵ緿μþ\ ¶«ÄÏ´óѧµç·¿Î¼þµÚ01ÕÂ-µç·ģÐͺ͵ç·¶¨ÂÉ.pdf ¶«ÄÏ´óѧµç·¿Î¼þµÚ02ÕÂ-µç×èµç·µÄµÈЧ±ä»».pdf ¶«ÄÏ´óѧµç·¿Î¼þµÚ03ÕÂ-µç×èµç·µÄÒ»°ã·ÖÎö.pdf ¶«ÄÏ´óѧµç·¿Î¼þµÚ04ÕÂ-µç·¶¨Àí.pdf ¶«ÄÏ´óѧµç·¿Î¼þµÚ06ÕÂ-´¢ÄÜÔª¼þ.pdf ¶«ÄÏ´óѧµç·¿Î¼þµÚ07ÕÂ-Ò»½×µç·ºÍ¶þ½×µç·µÄʱÓò·ÖÎö.pdf ¶«ÄÏ ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-09²ÄÁÏ¿ÆÑ§»ù´¡ÖªÊ¶µã×ܽá(Ŀ¼)
... ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-04-09
